Compare Procter & Gamble Health with Lupin - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH LUPIN PROCTER & GAMBLE HEALTH/
LUPIN
 
P/E (TTM) x 37.0 -18.8 - View Chart
P/BV x 9.8 2.1 469.1% View Chart
Dividend Yield % 3.1 1.0 302.8%  

Financials

 PROCTER & GAMBLE HEALTH   LUPIN
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-21
LUPIN
Mar-21
PROCTER & GAMBLE HEALTH/
LUPIN
5-Yr Chart
Click to enlarge
High Rs7,5001,122 668.5%   
Low Rs4,004576 695.4%   
Sales per share (Unadj.) Rs607.7334.2 181.8%  
Earnings per share (Unadj.) Rs106.527.0 393.9%  
Cash flow per share (Unadj.) Rs124.646.6 267.4%  
Dividends per share (Unadj.) Rs130.006.50 2,000.0%  
Avg Dividend yield %2.30.8 295.1%  
Book value per share (Unadj.) Rs421.6300.1 140.5%  
Shares outstanding (eoy) m16.60453.68 3.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x9.52.5 372.7%   
Avg P/E ratio x54.031.4 172.0%  
P/CF ratio (eoy) x46.218.2 253.4%  
Price / Book Value ratio x13.62.8 482.3%  
Dividend payout %122.124.0 507.7%   
Avg Mkt Cap Rs m95,477385,072 24.8%   
No. of employees `000NANA-   
Total wages/salary Rs m1,50528,259 5.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,087151,630 6.7%  
Other income Rs m1811,363 13.3%   
Total revenues Rs m10,268152,993 6.7%   
Gross profit Rs m2,46025,669 9.6%  
Depreciation Rs m3008,874 3.4%   
Interest Rs m81,406 0.6%   
Profit before tax Rs m2,33316,751 13.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5654,485 12.6%   
Profit after tax Rs m1,76812,266 14.4%  
Gross profit margin %24.416.9 144.1%  
Effective tax rate %24.226.8 90.4%   
Net profit margin %17.58.1 216.7%  
BALANCE SHEET DATA
Current assets Rs m10,389139,864 7.4%   
Current liabilities Rs m5,50784,361 6.5%   
Net working cap to sales %48.436.6 132.2%  
Current ratio x1.91.7 113.8%  
Inventory Days Days28969 417.9%  
Debtors Days Days215108 199.7%  
Net fixed assets Rs m9,39094,439 9.9%   
Share capital Rs m166907 18.3%   
"Free" reserves Rs m6,832135,229 5.1%   
Net worth Rs m6,998136,136 5.1%   
Long term debt Rs m0161 0.0%   
Total assets Rs m19,778234,302 8.4%  
Interest coverage x292.612.9 2,266.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.50.6 78.8%   
Return on assets %9.05.8 153.9%  
Return on equity %25.39.0 280.4%  
Return on capital %33.413.3 251.1%  
Exports to sales %00-   
Imports to sales %14.50-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m1,462NA-   
Fx inflow Rs m1,33151,027 2.6%   
Fx outflow Rs m1,46221,081 6.9%   
Net fx Rs m-13129,946 -0.4%   
CASH FLOW
From Operations Rs m2,47318,218 13.6%  
From Investments Rs m-323-12,396 2.6%  
From Financial Activity Rs m-3,866-18,853 20.5%  
Net Cashflow Rs m-1,716-13,031 13.2%  

Share Holding

Indian Promoters % 0.0 46.5 -  
Foreign collaborators % 51.8 0.3 18,507.1%  
Indian inst/Mut Fund % 14.5 41.9 34.6%  
FIIs % 6.6 14.7 44.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 53.2 90.5%  
Shareholders   66,289 378,547 17.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    



Today's Market

Sensex Tanks 750 Points as Energy, Auto Stocks Fall; Reliance, ONGC & Titan Top Losers(10:30 am)

Asian share markets erased early gains and fell in the negative territory tracking a sharp fall on Wall Street.

Related Views on News

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks(Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Best Monopoly Stocks to Own in 2022(Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

The One Smallcap Stock I'll Recommend Now(Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

How to Find the Next Multibagger Stock in the Market(Profit Hunter)

Jun 17, 2022

The #1 make or break factor in your portfolio you shouldn't ignore.

Is the Market Correction Over?(Fast Profits Daily)

Jun 17, 2022

In this video I'll show you why I think the market correction could be coming to an end.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Jul 1, 2022 03:31 PM

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH - ZENITH HEALTH COMPARISON

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS